netrashetty
Netra Shetty
Whole Foods Market (NASDAQ: WFMI) is a foods supermarket chain based in Austin, Texas which emphasizes "natural" and organic products. As of September 2009, the company operates 302 stores: 291 stores in 38 U.S. states and the District of Columbia; six stores in Canada; and five stores in the United Kingdom.[2]
The company is consistently ranked among the most socially responsible businesses[3] and placed third on the U.S. Environmental Protection Agency's list of Top 25 Green Power Partners.
Richard Marks, Global Head, TNS Media Research, will co-chair the conference, alongside Paul Todd, Product Management Director at Google. The symposium is a two day industry- leading event with speakers from a range of market- leading companies such as YouTube, Microsoft, ABC, ESPN and Ford, that aims to examine how audience measurement can catch the increasing complex behaviour of digital media consumers.
With a theme of ‘Audience Measurement 3.0’, the conference will present a fitting platform for discussions around next generation measurement services – spearheaded by platinum sponsors TNS’s innovative Set Top Box digital measurement services.
George Shababb, COO of TNS Media Research North America, will co-present one paper with Helen Katz, SVP of Starcom MediaVest Group entitled “From Data Evolution to Audience Revolution.” In this, George Shababb and Helen Katz will present ground breaking findings that show how addressable TV ads can be delivered to individual households and how second-by-second data are used to evaluate the outcomes.
George will also discuss RPD alongside other industry professionals in a main session forum entitled “The TV/video audience measurement challenge.”
Nick Burfitt, Global Director of RPD Services, TNS Media Research and Julian Dobinson of Sky will be examining the impact that the innovative Skyview Set Top Box service has had on Sky’s business since its launch in 2006: How is Sky the largest pay TV operator in the UK, using this data and what benefit is it to advertisers?
Also representing TNS will be Matthew Brosenne, Business Development Director, CSM Media Research in China, who will be discussing how media sponsors can drive ROI from the Olympics, and how Beijing 2008 may be the most critical commercial sporting event in recent history.
Richard Marks comments: “The future of audience measurement is at a pivotal point, and the key people who will shape its future will be at this world class event. We are extremely pleased to be so well represented, particularly the prominence that Set Top Box data will have across the conference, an area in which TNS continues to be the thought leader.”
Cosmeceuticals are a marriage between cosmetics and pharmaceuticals but manufacturers cannot maintain that a cosmeceutical product has drug-like qualities. In such case, it is no longer considered a cosmeceutical but a drug, which requires review and approval for distribution by regulatory bodies such as the Food, Drug, and Cosmetic Act (FDA) in the U.S. and regulatory agencies in the EU countries. While the FDA does not recognize the term "cosmeceutical," the cosmetic industry uses this word to refer to cosmetic products that have medicinal or drug-like benefits.
The FDA defines drugs as those products which cure, treat, mitigate or prevent disease or that affect the structure or function of the human body. So, while drugs are subject to a review and approval process by FDA, cosmetics are not approved by the FDA prior to sale. If a product has drug properties (Botox), it must be approved as a drug. In contrast, cosmeceuticals do not require regulatory approval and consumers can purchase them without a prescription.
Examples of popular cosmeceuticals include the following:
Moisturizers
Retinoids
Antioxidants
Depigmentation agents
In general, vitamins, herbs, various oils, and botanical extracts may be used in cosmeceuticals, but the manufacturer may not claim that these products penetrate beyond the skin's surface layers or that they have drug like or therapeutic effects. For cosmetic labels, no division between active ingredients and other ingredients is required; they are all listed together.
Market Metrics
The United States is the world's largest cosmetics market, valued at US $45.4 billon, followed by Japan at US $21.9 billon, France at US $12.1 billion, Germany at US $11.6 billion, the UK at US $10.1 billion, and Italy at US $8.5 billion.
Overall, growth in skincare cosmeceuticals in the United States outpaces that of Europe. Between 2006 and 2011, the U.S. market for cosmeceutical skincare is forecast to grow from US $3.5 billion to US $4.5 billion with a predicted compound annual growth rate of 5.5%, compared to only 4.9 percent in Europe.
Demand in the U.S. for cosmeceuticals - loosely defined as cosmetic products that have medicinal or drug-like benefits - is projected to increase 8.5% per year to more than $8 billion in 2010. The skin care segment within the cosmeceutical market will reportedly account for 60 percent of all cosmeceutical demand by 2010.
The anti-aging products sector and increased mass-market distribution of prestige products are the primary drivers of the U.S. cosmeceutical market. For instance, retail sales of skin care products, which include both mass and prestige products, grew by 4.8 percent to $5.8 billion in 2005 from 2004. Additionally, retail sales of anti-aging products increased 4.4 percent to an estimated $505 million. It is anticipated that sales of other skin care products with the exception of facial cleansers such as moisturizers and hand and body lotions will follow a similar growth pattern.
With respect to increased mass-market distribution of skin care products, mass retail sales (excluding Wal-Mart) of anti-aging skin care products rose 15 percent between 2001 and 2005. It is anticipated that that anti-aging skin product sales in this channel will have a compound annual growth rate of 11.3 percent through 2010.
The foundation of the anti-aging segment's double-digit growth is in the development of new and formulation-improved cosmeceutical products. Skin care will reportedly account for 60 percent of all cosmeceutical demand by 2010.
Between 2001 and 2006, nourishing and anti-aging products was one of the fastest growing sub sectors within the global cosmetic market, growing 99 percent to reach sales of $12.7 billion. The U.S. market value for nourishing and anti-aging products for skin care is forecasted to reach $2.6 billion in 2011, a 24 percent growth from last year's estimate of $2.1 billion. Last year's total value of U.S. facial care products, which include moisturizers, anti-agers/nourishers, cleansers, toners, face masks and lip moisturizers, was estimated at $5.87 billion and is forecasts to reach $6.1 billion in 2011.
Skincare cosmeceuticals account for around 80 percent of the total U.S. and European cosmeceutical market. Professional products - cosmetic products that are doctor-endorsed or are sold in clinics/spas - are said to have the fastest growth among cosmeceutical products. Physicians and spa professionals, however, now face stiff competition from retail channels such as drugstores and other mass merchandisers. For instance Procter & Gamble recently acquired the Doctor's Dermatologic Formula skin care line. A large company such as P&G has the financial means to market and sell products and support a business in a way that doctors and spas are unable to do on their own.
The professional skin care product market had estimated sales of US $870 million in 2005, representing more than five straight years of double-digit growth. Sales through the medical channel have grown by more than 17 percent from 2005, a boost that helps mitigate a decline in the number of cosmetic procedures performed by physicians.
By 2011, the U.S. skin care market value is forecasted to reach US $8 billion from an estimated $7.78 billion in 2005. Global skin care sales are projected to grow by 25 percent to reach US $69.6 billion in 2010 from 2005. Anticellulite body care and anti-aging products will continue to be a key source of dynamism in the longer term. Moreover, the cosmeceutical market will be faced with intense pricing competition due to the growing market penetration of private label cosmeceutical brands and the rapid commercialization of innovative ingredients and products.
The company is consistently ranked among the most socially responsible businesses[3] and placed third on the U.S. Environmental Protection Agency's list of Top 25 Green Power Partners.
Richard Marks, Global Head, TNS Media Research, will co-chair the conference, alongside Paul Todd, Product Management Director at Google. The symposium is a two day industry- leading event with speakers from a range of market- leading companies such as YouTube, Microsoft, ABC, ESPN and Ford, that aims to examine how audience measurement can catch the increasing complex behaviour of digital media consumers.
With a theme of ‘Audience Measurement 3.0’, the conference will present a fitting platform for discussions around next generation measurement services – spearheaded by platinum sponsors TNS’s innovative Set Top Box digital measurement services.
George Shababb, COO of TNS Media Research North America, will co-present one paper with Helen Katz, SVP of Starcom MediaVest Group entitled “From Data Evolution to Audience Revolution.” In this, George Shababb and Helen Katz will present ground breaking findings that show how addressable TV ads can be delivered to individual households and how second-by-second data are used to evaluate the outcomes.
George will also discuss RPD alongside other industry professionals in a main session forum entitled “The TV/video audience measurement challenge.”
Nick Burfitt, Global Director of RPD Services, TNS Media Research and Julian Dobinson of Sky will be examining the impact that the innovative Skyview Set Top Box service has had on Sky’s business since its launch in 2006: How is Sky the largest pay TV operator in the UK, using this data and what benefit is it to advertisers?
Also representing TNS will be Matthew Brosenne, Business Development Director, CSM Media Research in China, who will be discussing how media sponsors can drive ROI from the Olympics, and how Beijing 2008 may be the most critical commercial sporting event in recent history.
Richard Marks comments: “The future of audience measurement is at a pivotal point, and the key people who will shape its future will be at this world class event. We are extremely pleased to be so well represented, particularly the prominence that Set Top Box data will have across the conference, an area in which TNS continues to be the thought leader.”
Cosmeceuticals are a marriage between cosmetics and pharmaceuticals but manufacturers cannot maintain that a cosmeceutical product has drug-like qualities. In such case, it is no longer considered a cosmeceutical but a drug, which requires review and approval for distribution by regulatory bodies such as the Food, Drug, and Cosmetic Act (FDA) in the U.S. and regulatory agencies in the EU countries. While the FDA does not recognize the term "cosmeceutical," the cosmetic industry uses this word to refer to cosmetic products that have medicinal or drug-like benefits.
The FDA defines drugs as those products which cure, treat, mitigate or prevent disease or that affect the structure or function of the human body. So, while drugs are subject to a review and approval process by FDA, cosmetics are not approved by the FDA prior to sale. If a product has drug properties (Botox), it must be approved as a drug. In contrast, cosmeceuticals do not require regulatory approval and consumers can purchase them without a prescription.
Examples of popular cosmeceuticals include the following:
Moisturizers
Retinoids
Antioxidants
Depigmentation agents
In general, vitamins, herbs, various oils, and botanical extracts may be used in cosmeceuticals, but the manufacturer may not claim that these products penetrate beyond the skin's surface layers or that they have drug like or therapeutic effects. For cosmetic labels, no division between active ingredients and other ingredients is required; they are all listed together.
Market Metrics
The United States is the world's largest cosmetics market, valued at US $45.4 billon, followed by Japan at US $21.9 billon, France at US $12.1 billion, Germany at US $11.6 billion, the UK at US $10.1 billion, and Italy at US $8.5 billion.
Overall, growth in skincare cosmeceuticals in the United States outpaces that of Europe. Between 2006 and 2011, the U.S. market for cosmeceutical skincare is forecast to grow from US $3.5 billion to US $4.5 billion with a predicted compound annual growth rate of 5.5%, compared to only 4.9 percent in Europe.
Demand in the U.S. for cosmeceuticals - loosely defined as cosmetic products that have medicinal or drug-like benefits - is projected to increase 8.5% per year to more than $8 billion in 2010. The skin care segment within the cosmeceutical market will reportedly account for 60 percent of all cosmeceutical demand by 2010.
The anti-aging products sector and increased mass-market distribution of prestige products are the primary drivers of the U.S. cosmeceutical market. For instance, retail sales of skin care products, which include both mass and prestige products, grew by 4.8 percent to $5.8 billion in 2005 from 2004. Additionally, retail sales of anti-aging products increased 4.4 percent to an estimated $505 million. It is anticipated that sales of other skin care products with the exception of facial cleansers such as moisturizers and hand and body lotions will follow a similar growth pattern.
With respect to increased mass-market distribution of skin care products, mass retail sales (excluding Wal-Mart) of anti-aging skin care products rose 15 percent between 2001 and 2005. It is anticipated that that anti-aging skin product sales in this channel will have a compound annual growth rate of 11.3 percent through 2010.
The foundation of the anti-aging segment's double-digit growth is in the development of new and formulation-improved cosmeceutical products. Skin care will reportedly account for 60 percent of all cosmeceutical demand by 2010.
Between 2001 and 2006, nourishing and anti-aging products was one of the fastest growing sub sectors within the global cosmetic market, growing 99 percent to reach sales of $12.7 billion. The U.S. market value for nourishing and anti-aging products for skin care is forecasted to reach $2.6 billion in 2011, a 24 percent growth from last year's estimate of $2.1 billion. Last year's total value of U.S. facial care products, which include moisturizers, anti-agers/nourishers, cleansers, toners, face masks and lip moisturizers, was estimated at $5.87 billion and is forecasts to reach $6.1 billion in 2011.
Skincare cosmeceuticals account for around 80 percent of the total U.S. and European cosmeceutical market. Professional products - cosmetic products that are doctor-endorsed or are sold in clinics/spas - are said to have the fastest growth among cosmeceutical products. Physicians and spa professionals, however, now face stiff competition from retail channels such as drugstores and other mass merchandisers. For instance Procter & Gamble recently acquired the Doctor's Dermatologic Formula skin care line. A large company such as P&G has the financial means to market and sell products and support a business in a way that doctors and spas are unable to do on their own.
The professional skin care product market had estimated sales of US $870 million in 2005, representing more than five straight years of double-digit growth. Sales through the medical channel have grown by more than 17 percent from 2005, a boost that helps mitigate a decline in the number of cosmetic procedures performed by physicians.
By 2011, the U.S. skin care market value is forecasted to reach US $8 billion from an estimated $7.78 billion in 2005. Global skin care sales are projected to grow by 25 percent to reach US $69.6 billion in 2010 from 2005. Anticellulite body care and anti-aging products will continue to be a key source of dynamism in the longer term. Moreover, the cosmeceutical market will be faced with intense pricing competition due to the growing market penetration of private label cosmeceutical brands and the rapid commercialization of innovative ingredients and products.
Last edited: